Goldman Cashes In Valeant Shares Backing CEO's $100M Debt
Valeant Pharmaceuticals said Friday that Goldman Sachs has sold 1.3 million Valeant shares it had been holding as collateral for $100 million in loans taken out by the drugmaker's CEO, a...To view the full article, register now.
Already a subscriber? Click here to view full article